Steven H Holtzman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven H Holtzman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven H Holtzman. Steven H Holtzman is EVP Corporate Development in BIOGEN INC. ($IDPH) and Director in ANADYS PHARMACEUTICALS INC ($ANDS).
Latest Insider Trading Transactions of Steven H Holtzman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | J | 0.00 | 1,149 | 0 | 3,462 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 579 | 0 | 4,611 | |
| Feb 25 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 258.99 | 273 | 70,704 | 8,326 | 8.6 K to 8.3 K (-3.17 %) |
| Feb 25 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 579 | 0 | 8,599 | 8 K to 8.6 K (+7.22 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | J | 0.00 | 1,394 | 0 | 2,448 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,142 | 0 | 2,147 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 1,052 | 0 | 3,842 | |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 247.22 | 819 | 202,473 | 8,020 | 8.8 K to 8 K (-9.27 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,142 | 0 | 8,839 | 6.7 K to 8.8 K (+31.98 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 247.22 | 495 | 122,374 | 6,697 | 7.2 K to 6.7 K (-6.88 %) |
| Feb 17 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 1,052 | 0 | 7,192 | 6.1 K to 7.2 K (+17.13 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,709 | 0 | 0 | |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 250.77 | 890 | 223,185 | 6,140 | 7 K to 6.1 K (-12.66 %) |
| Feb 09 2016 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,709 | 0 | 7,030 | 4.3 K to 7 K (+62.69 %) |
| Feb 25 2015 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | A | 0.00 | 5,190 | 0 | 5,190 | |
| May 29 2009 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
| May 30 2008 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 2.73 | 15,000 | 40,950 | 15,000 | |
| Sep 05 2007 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 2.25 | 5,000 | 11,250 | 5,000 | |
| Jun 05 2007 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | |
| Sep 01 2006 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 3.73 | 5,000 | 18,650 | 5,000 | |
| Jun 02 2006 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 10.46 | 5,000 | 52,300 | 5,000 | |
| Sep 06 2005 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 12.16 | 5,000 | 60,800 | 5,000 | |
| Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 8.37 | 3,750 | 31,388 | 3,750 |
Page: 1